{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:19:03Z","timestamp":1787678343502,"version":"build-2784847793"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.thromres.2026.109803","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:47:24Z","timestamp":1786690044000},"page":"109803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-0818","authenticated-orcid":false,"given":"Viola J.F.","family":"Strijbis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Lei","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9102-710X","authenticated-orcid":false,"given":"Dorothea","family":"Gobbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-5759","authenticated-orcid":false,"given":"Jeroen","family":"Eikenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9932-718X","authenticated-orcid":false,"given":"Ying Poi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-817X","authenticated-orcid":false,"given":"Mettine H.A.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.thromres.2026.109803_bb0005","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/j.1460-2075.1989.tb08511.x","article-title":"The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment","volume":"8","author":"Bode","year":"1989","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.thromres.2026.109803_bb0010","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.thromres.2026.109803_bb0015","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1073\/pnas.74.12.5260","article-title":"Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation","volume":"74","author":"Osterud","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 1(0 1)","key":"10.1016\/j.thromres.2026.109803_bb0020","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.thromres.2014.03.020","article-title":"The mechanism underlying activation of factor IX by factor XIa","volume":"133","author":"Gailani","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109803_bb0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/ar50123a006","article-title":"Structural basis of the activation and action of trypsin","volume":"11","author":"Huber","year":"1978","journal-title":"Acc. Chem. Res."},{"issue":"21","key":"10.1016\/j.thromres.2026.109803_bb0030","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.2023023276","article-title":"Blood coagulation factor IX: structural insights impacting hemophilia B therapy","volume":"144","author":"Bos","year":"2024","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.thromres.2026.109803_bb0035","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1021\/bi992735q","article-title":"Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII","volume":"39","author":"Kolkman","year":"2000","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.thromres.2026.109803_bb0040","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1074\/jbc.M210722200","article-title":"Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop","volume":"278","author":"Sichler","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.thromres.2026.109803_bb0045","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1042\/BCJ20160336","article-title":"Releasing the brakes in coagulation Factor IXa by co-operative maturation of the substrate-binding site","volume":"473","author":"Kristensen","year":"2016","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.thromres.2026.109803_bb0050","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/S0021-9258(19)69627-4","article-title":"The role of phospholipid and factor VIIIa in the activation of bovine factor X","volume":"256","author":"van Dieijen","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.thromres.2026.109803_bb0055","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1055\/s-0038-1660091","article-title":"The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX","volume":"54","author":"Mertens","year":"1985","journal-title":"Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.thromres.2026.109803_bb0060","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1016\/S0021-9258(18)41886-8","article-title":"The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study","volume":"267","author":"Mutucumarana","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.thromres.2026.109803_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"10.1016\/j.thromres.2026.109803_bb0070","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/jth.12731","article-title":"Next generation FIX muteins with FVIII-independent activity for alternative treatment of hemophilia a","volume":"12","author":"Quade-Lyssy","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109803_bb0075","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jtha.2023.02.019","article-title":"A factor IX variant that functions independently of factor VIII mitigates the hemophilia A phenotype in patient plasma","volume":"21","author":"Strijbis","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109803_bb0080","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2004-08-2990","article-title":"Factor IX variants improve gene therapy efficacy for hemophilia B","volume":"105","author":"Schuettrumpf","year":"2005","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.thromres.2026.109803_bb0085","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.93.20.11068","article-title":"Identification of the endothelial cell binding site for factor IX","volume":"93","author":"Cheung","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.thromres.2026.109803_bb0090","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","article-title":"X-linked thrombophilia with a mutant factor IX (factor IX Padua)","volume":"361","author":"Simioni","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2026.109803_bb0095","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jth.12572","article-title":"Oral gene therapy for hemophilia B using chitosan-formulated FIX mutants","volume":"12","author":"Quade-Lyssy","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109803_bb0100","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1055\/s-0040-1715441","article-title":"Evolutionary adaptations in Pseudonaja textilis venom factor X induce zymogen activity and resistance to the intrinsic Tenase complex","volume":"120","author":"Schreuder","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2026.109803_bb0105","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jtha.2024.04.022","article-title":"Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors","volume":"22","author":"Schreuder","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109803_bb0110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41467-017-00647-9","article-title":"Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors","volume":"8","author":"Verhoef","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.thromres.2026.109803_bb0115","series-title":"Williams Hematology","article-title":"Molecular biology and biochemistry of the coagulation factors and pathways of hemostasis","author":"Bos","year":"2026"},{"issue":"8","key":"10.1016\/j.thromres.2026.109803_bb0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0969-2126(99)80125-7","article-title":"Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding","volume":"7","author":"Hopfner","year":"1999","journal-title":"Structure"},{"issue":"7","key":"10.1016\/j.thromres.2026.109803_bb0125","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/jcc.21720","article-title":"Web servers and services for electrostatics calculations with APBS and PDB2PQR","volume":"32","author":"Unni","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.thromres.2026.109803_bb0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.thromres.2026.109803_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"issue":"16","key":"10.1016\/j.thromres.2026.109803_bb0140","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.thromres.2026.109803_bb0145","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41592-019-0506-8","article-title":"Promoting transparency and reproducibility in enhanced molecular simulations","volume":"16","author":"consortium P","year":"2019","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.thromres.2026.109803_bb0150","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.cpc.2013.09.018","article-title":"PLUMED 2: new feathers for an old bird","volume":"185","author":"Tribello","year":"2014","journal-title":"Comput. Phys. Commun."},{"issue":"23","key":"10.1016\/j.thromres.2026.109803_bb0155","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1093\/bioinformatics\/btr550","article-title":"MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories","volume":"27","author":"Schmidtke","year":"2011","journal-title":"Bioinformatics"},{"issue":"14","key":"10.1016\/j.thromres.2026.109803_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128683","article-title":"Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity","volume":"5","author":"Samelson-Jones","year":"2019","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.thromres.2026.109803_bb0165","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood.2022018083","article-title":"Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo","volume":"141","author":"Ivanciu","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2026.109803_bb0170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1160\/TH04-10-0706","article-title":"Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B","volume":"93","author":"Dargaud","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2026.109803_bb0175","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s12185-009-0450-y","article-title":"A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia a","volume":"90","author":"Matsumoto","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"11","key":"10.1016\/j.thromres.2026.109803_bb0180","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/jth.13134","article-title":"Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive","volume":"13","author":"Waters","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109803_bb0185","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1055\/a-2101-7961","article-title":"Sensitive measurement of clinically relevant factor VIII levels in thrombin generation assays requires presence of factor XIa","volume":"123","author":"van de Berg","year":"2023","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2026.109803_bb0190","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1538-7836.2011.04358.x","article-title":"Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia a","volume":"9","author":"Ninivaggi","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109803_bb0195","first-page":"133","article-title":"FIXa-triggered thrombin generation correlates with FVIII levels less than 1% in reconstituted plasma mimicking samples obtained from patients with severe hemophilia A","volume":"37","author":"Huang","year":"2026","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2026.109803_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2516.2008.01737.x","article-title":"New assays for monitoring haemophilia treatment","volume":"14","author":"Shima","year":"2008","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.thromres.2026.109803_bb0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.htct.2018.08.007","article-title":"Standardization and evaluation of the performance of the thrombin generation test under hypo- and hypercoagulability conditions","volume":"41","author":"Duarte","year":"2019","journal-title":"Hematol. Transfus. Cell Ther."},{"issue":"9","key":"10.1016\/j.thromres.2026.109803_bb0210","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3324\/haematol.2020.253047","article-title":"Thrombin generation: a global coagulation procedure to investigate hypo- and hyper-coagulability","volume":"105","author":"Tripodi","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.thromres.2026.109803_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100018","article-title":"Thrombin generation and implications for hemophilia therapies: a narrative review","volume":"7","author":"Sidonio","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2026.109803_bb0220","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1538-7836.2009.03560.x","article-title":"Factor IX mutants with enhanced catalytic activity","volume":"7","author":"Hartmann","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109803_bb0225","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood-2011-05-353672","article-title":"Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice","volume":"119","author":"Milanov","year":"2012","journal-title":"Blood"},{"issue":"D1","key":"10.1016\/j.thromres.2026.109803_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1134","article-title":"The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database","volume":"46","author":"Rawlings","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.thromres.2026.109803_bb0235","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.23645","article-title":"Mutation analysis of a cohort of US patients with hemophilia B","volume":"89","author":"Li","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.thromres.2026.109803_bb0240","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.jtha.2023.08.030","article-title":"Crippling down factor IX for therapeutic gain","volume":"21","author":"Strijbis","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"25","key":"10.1016\/j.thromres.2026.109803_bb0245","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1021\/bi00076a004","article-title":"Mutations in the catalytic domain of factor IX that are related to the subclass hemophilia Bm","volume":"32","author":"Hamaguchi","year":"1993","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.thromres.2026.109803_bb0250","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1074\/jbc.RA119.009183","article-title":"Beating tissue factor at its own game: design and properties of a soluble tissue factor-independent coagulation factor VIIa","volume":"295","author":"Sorensen","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.thromres.2026.109803_bb0255","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/bloodadvances.2019000405","article-title":"Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants","volume":"5","author":"Samelson-Jones","year":"2021","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.thromres.2026.109803_bb0260","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/2211-5463.12653","article-title":"Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides","volume":"9","author":"Fang","year":"2019","journal-title":"FEBS Open Bio"},{"issue":"29","key":"10.1016\/j.thromres.2026.109803_bb0265","doi-asserted-by":"crossref","first-page":"20529","DOI":"10.1016\/S0021-9258(19)36713-4","article-title":"The binding of human factor IX to endothelial cells is mediated by residues 3-11","volume":"267","author":"Cheung","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.thromres.2026.109803_bb0270","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.1074\/jbc.272.27.16717","article-title":"Human factor IX binds to specific sites on the collagenous domain of collagen IV","volume":"272","author":"Wolberg","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.thromres.2026.109803_bb0275","doi-asserted-by":"crossref","first-page":"721","DOI":"10.18388\/abp.1999_4144","article-title":"Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene","volume":"46","author":"Wulff","year":"1999","journal-title":"Acta Biochim. Pol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109803_bb0280","first-page":"635","article-title":"Molecular genotyping of the Italian cohort of patients with hemophilia B","volume":"90","author":"Belvini","year":"2005","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.thromres.2026.109803_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1482","article-title":"Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations","volume":"8","author":"Huang","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"issue":"D1","key":"10.1016\/j.thromres.2026.109803_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.thromres.2026.109803_bb0295","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1101\/gr.9.8.677","article-title":"dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation","volume":"9","author":"Sherry","year":"1999","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.thromres.2026.109803_bb0300","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/j.1460-2075.1989.tb03474.x","article-title":"Molecular pathology of haemophilia B","volume":"8","author":"Green","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.thromres.2026.109803_bb0305","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1538-7836.2009.03545.x","article-title":"Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV","volume":"7","author":"Gui","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109803_bb0310","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2016-01-696104","article-title":"Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice","volume":"128","author":"Cooley","year":"2016","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.thromres.2026.109803_bb0315","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1182\/blood.2018884015","article-title":"Dysfunctional endogenous FIX impairs prophylaxis in a mouse hemophilia B model","volume":"133","author":"Cooley","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2026.109803_bb0320","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtha.2023.11.023","article-title":"Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding","volume":"22","author":"Leuci","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109803_bb0325","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.thromres.2026.109803_bb0330","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0076-6879(93)22029-F","article-title":"Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII","volume":"222","author":"Berkner","year":"1993","journal-title":"Methods Enzymol."},{"issue":"12","key":"10.1016\/j.thromres.2026.109803_bb0335","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1111\/j.1538-7836.2005.01478.x","article-title":"Post-translational modifications in proteins involved in blood coagulation","volume":"3","author":"Hansson","year":"2005","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:28:31Z","timestamp":1787675311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826002227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":67,"alternative-id":["S0049384826002227"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109803","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109803"}}